Clinical Trial Update: Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107

View source ↗

Summary

An update on the CALGB-30107 trial reports on biomarkers of angiogenesis and disease in patients with unresectable malignant mesothelioma. The trial has been te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Malignant Mesothelioma | Status: TERMINATED